Blau Farmaceutica SA
BOVESPA:BLAU3

Watchlist Manager

Blau Farmaceutica SA

BOVESPA:BLAU3

Watchlist

Dividends

Price: 14.82 BRL -1.33% Market Closed

Market Cap: 2.6B BRL

Have any thoughts about
Blau Farmaceutica SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 14.82 BRL

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BLAU3 Alert

Blau Farmaceutica SA

14.82

-0.20 (-1.33%)

52 Week Range	9.2736 17
Price Target

We'll email you a reminder when the closing price reaches BRL.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Blau Farmaceutica SA

What unique competitive advantages
does Blau Farmaceutica SA hold over its rivals?

What risks and challenges
does Blau Farmaceutica SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Blau Farmaceutica SA.

What unique competitive advantages
does Blau Farmaceutica SA hold over its rivals?

What risks and challenges
does Blau Farmaceutica SA face in the near future?

Summarize the latest earnings call
of Blau Farmaceutica SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Blau Farmaceutica SA.

Provide P/S
for Blau Farmaceutica SA.

Provide P/E
for Blau Farmaceutica SA.

Provide P/OCF
for Blau Farmaceutica SA.

Provide P/FCFE
for Blau Farmaceutica SA.

Provide P/B
for Blau Farmaceutica SA.

Provide EV/S
for Blau Farmaceutica SA.

Provide EV/GP
for Blau Farmaceutica SA.

Provide EV/EBITDA
for Blau Farmaceutica SA.

Provide EV/EBIT
for Blau Farmaceutica SA.

Provide EV/OCF
for Blau Farmaceutica SA.

Provide EV/FCFF
for Blau Farmaceutica SA.

Provide EV/IC
for Blau Farmaceutica SA.

Show me price targets
for Blau Farmaceutica SA made by professional analysts.

What are the Revenue projections
for Blau Farmaceutica SA?

How accurate were the past Revenue estimates
for Blau Farmaceutica SA?

What are the Net Income projections
for Blau Farmaceutica SA?

How accurate were the past Net Income estimates
for Blau Farmaceutica SA?

What are the EPS projections
for Blau Farmaceutica SA?

How accurate were the past EPS estimates
for Blau Farmaceutica SA?

What are the EBIT projections
for Blau Farmaceutica SA?

How accurate were the past EBIT estimates
for Blau Farmaceutica SA?

Compare the revenue forecasts
for Blau Farmaceutica SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Blau Farmaceutica SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Blau Farmaceutica SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Blau Farmaceutica SA compared to its peers.

Compare the P/E ratios
of Blau Farmaceutica SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Blau Farmaceutica SA with its peers.

Analyze the financial leverage
of Blau Farmaceutica SA compared to its main competitors.

Show all profitability ratios
for Blau Farmaceutica SA.

Provide ROE
for Blau Farmaceutica SA.

Provide ROA
for Blau Farmaceutica SA.

Provide ROIC
for Blau Farmaceutica SA.

Provide ROCE
for Blau Farmaceutica SA.

Provide Gross Margin
for Blau Farmaceutica SA.

Provide Operating Margin
for Blau Farmaceutica SA.

Provide Net Margin
for Blau Farmaceutica SA.

Provide FCF Margin
for Blau Farmaceutica SA.

Show all solvency ratios
for Blau Farmaceutica SA.

Provide D/E Ratio
for Blau Farmaceutica SA.

Provide D/A Ratio
for Blau Farmaceutica SA.

Provide Interest Coverage Ratio
for Blau Farmaceutica SA.

Provide Altman Z-Score Ratio
for Blau Farmaceutica SA.

Provide Quick Ratio
for Blau Farmaceutica SA.

Provide Current Ratio
for Blau Farmaceutica SA.

Provide Cash Ratio
for Blau Farmaceutica SA.

What is the historical Revenue growth
over the last 5 years for Blau Farmaceutica SA?

What is the historical Net Income growth
over the last 5 years for Blau Farmaceutica SA?

What is the current Free Cash Flow
of Blau Farmaceutica SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Blau Farmaceutica SA.

P/E
Price to Earnings

14.1

Current

12.8

Median

22.7

Industry

Higher than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

14.1

Market Cap

2.6B BRL

Net Income

187m BRL

All Countries

Forward Multiples

			Market Cap	P/E
BR		Blau Farmaceutica SA BOVESPA:BLAU3	2.6B BRL	14.1
FR		Pharnext SCA OTC:PNEXF	6T USD	-180 080
US		Abbvie Inc NYSE:ABBV	314.7B USD	61.9
US		Amgen Inc NASDAQ:AMGN	157B USD	37.1
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	115.9B USD	-241.6
US		Gilead Sciences Inc NASDAQ:GILD	112.2B USD	890.3
US	E	Epizyme Inc F:EPE	94.1B EUR	-474.5
AU		CSL Ltd ASX:CSL	133.6B AUD	32.9
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	82.6B USD	17.8
US	S	Seagen Inc F:SGT	39.3B EUR	-54.9
NL		argenx SE XBRU:ARGX	34.5B EUR	-130.6

				Earnings Growth
BR		Blau Farmaceutica SA BOVESPA:BLAU3	Average P/E: 175.7 14.1	29%
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -180 080	N/A
US		Abbvie Inc NYSE:ABBV	61.9	412%
US		Amgen Inc NASDAQ:AMGN	37.1	73%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -241.6	42%
US		Gilead Sciences Inc NASDAQ:GILD	890.3	75%
US	E	Epizyme Inc F:EPE	Negative Multiple: -474.5	N/A
AU		CSL Ltd ASX:CSL	32.9	65%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	17.8	43%
US	S	Seagen Inc F:SGT	Negative Multiple: -54.9	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -130.6	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

12.4

2-Years Forward

P/E

9.5

3-Years Forward

P/E

8.2

Blau Farmaceutica SA
BOVESPA:BLAU3

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Blau Farmaceutica SA BOVESPA:BLAU3

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Blau Farmaceutica SA
BOVESPA:BLAU3

P/E
Price to Earnings